EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma

被引：0

作者：

Alexander J. J. Smits

J. Alain Kummer

John W. J. Hinrichs

Gerarda J. M. Herder

Karen C. Scheidel-Jacobse

N. Mehdi Jiwa

T. Emiel G. Ruijter

Peet T. G. A. Nooijen

Monica G. Looijen-Salamon

Marjolijn J. L. Ligtenberg

Frederik B. Thunnissen

Daniëlle A. M. Heideman

Roel A. de Weger

Aryan Vink

机构：

[1] St. Antonius Hospital,Department of Pathology

[2] University Medical Center Utrecht,Department of Pathology

[3] St. Antonius Hospital,Department of Pulmonary Diseases

[4] Medical Center Alkmaar,Department of Pathology

[5] Rijnstate Hospital,Department of Pathology

[6] Jeroen Bosch Hospital,Department of Pathology

[7] Radboud University Nijmegen Medical Centre,Department of Pathology

[8] VU University Medical Center,Department of Pathology

来源：

Cellular Oncology | 2012年 / 35卷

关键词：

Non-small cell lung cancer; Adenocarcinoma; Metastasis; Pleural effusion;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：189 / 196

页数：7

共 50 条

[31] Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation
Tanizaki, Junko
Banno, Eri
Togashi, Yosuke
Hayashi, Hidetoshi
Sakai, Kazuko
Takeda, Masayuki
Kaneda, Hiroyasu
Nishio, Kazuto
Nakagawa, Kazuhiko
LUNG CANCER, 2016, 101 : 11 - 15
[32] Segmentectomy for Lung Adenocarcinoma: The Impact of EGFR Mutation Status on Recurrence
Hyun, K.
Park, S.
Lee, H. J.
Park, I. K.
Kim, Y.
Kang, C. H.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2351 - S2351
[33] Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
Girard, N.
Sima, C. S.
Jackman, D. M.
Sequist, L. V.
Chen, H.
Yang, J. C-H.
Ji, H.
Waltman, B.
Rosell, R.
Taron, M.
Zakowski, M. F.
Ladanyi, M.
Riely, G.
Pao, W.
EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (02) : 366 - 372
[34] Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation
Kawamura, Takahisa
Kenmotsu, Hirotsugu
Kobayashi, Haruki
Omori, Shota
Nakashima, Kazuhisa
Wakuda, Kazushige
Ono, Akira
Naito, Tateaki
Murakami, Haruyasu
Mori, Keita
Endo, Masahiro
Takahashi, Toshiaki
INVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 194 - 201
[35] Terminal respiratory unit type lung adenocarcinoma is associated with distinctive EGFR immunoreactivity and EGFR mutations
Peterson, Michael R.
Piao, Zhe
Bazhenova, Lyudmila A.
Weidner, Noel
Yi, Eunhee S.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (03) : 242 - 247
[36] Prognostic Impact of EGFR Driver Mutations on Postoperative Disease Recurrence in Lung Adenocarcinoma
Okamoto, Tatsuro
Kitahara, Hirokazu
Shimamatsu, Shinichiro
Katsura, Masakazu
Takada, Kazuki
Fujishita, Takatoshi
Suzuki, Yuzo
Morodomi, Yosuke
Tagawa, Tetsuzo
Maehara, Yoshihiko
ANTICANCER RESEARCH, 2016, 36 (06) : 3057 - 3063
[37] Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix A case report
Wang, Yong
Chen, Lin
Wang, Zhi
Liu, Shubin
MEDICINE, 2020, 99 (42) : E22636
[38] Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model
Teixeira, Lisete
Acencio, Milena
Alvarenga, Vanessa
Silva, Gabriela
Brito, Zenaide
Fernezlian, Sandra
Puka, Juliana
Martins, Vanessa
Capelozzi, Vera
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1276 - S1277
[39] Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic Variation
Soraas, Lars
Stebbing, Justin
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (03) : 454 - 458
[40] EGFR, KRAS and ROS1 variants coexist in a lung adenocarcinoma patient
Ju, Lixia
Han, Mingquan
Zhao, Chao
Li, Xuefei
LUNG CANCER, 2016, 95 : 94 - 97

← 1 2 3 4 5 →